The global mesoporous silica market was valued at USD 170.1 million in 2022 and is anticipated to reach USD 388.7 million by 2030, growing at a CAGR of 10.4% from 2023 to 2030. The increasing adoption of the product across various industries—including chemicals, wastewater treatment, and pharmaceuticals—continues to be a key growth driver for the market.

Mesoporous silica’s thermal stability, favorable chemical attributes, and biocompatibility make it a promising material in the pharmaceutical sector, especially for drug delivery systems. Ongoing research and development in cancer therapies utilizing mesoporous silica is further stimulating market growth. Its broad applicability in wastewater treatment, chemical synthesis, and the increasing government and private sector investment in biotechnology is expected to reinforce demand over the coming years.

In the U.S., the market for mesoporous silica is expected to grow steadily between 2023 and 2030. Meanwhile, China is emerging as a high-growth market driven by rapid industrial development and supportive pharmaceutical and chemical sector dynamics. The country’s advantage in raw material availability, favorable trade policies, and its role as a manufacturing hub have attracted numerous multinational corporations to set up operations.

Conversely, stringent regulatory frameworks in regions such as Europe and North America may limit market expansion. Regulatory bodies, including the U.S. Environmental Protection Agency (EPA) and the EU Health and Consumer Protection Directorate, are currently assessing potential environmental and health impacts associated with nanoparticles, including mesoporous silica. Presently, the product remains in a research-intensive phase, with a limited number of active market participants. Nevertheless, growing awareness of its benefits is likely to broaden its applications in the near future.

Key Market Trends & Insights

• North America led the global market in 2022, contributing a 36.2% revenue share.

• The Asia Pacific region is projected to grow at the fastest CAGR of 11.5% during the forecast period.

• Among product types, the SBA series segment accounted for the largest revenue share of 44.0% in 2022, and is also expected to expand at the fastest CAGR of 11.5% through 2030.

• On the basis of application, the drug delivery segment held the dominant position with a 42.9% revenue share in 2022.

Order a free sample PDF of the Mesoporous Silica Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2022 Market Size: USD 170.1 Million

• 2030 Projected Market Size: USD 388.7 Million

• CAGR (2023–2030): 10.4%

• North America: Largest market in 2022

• Asia Pacific: Fastest growing region

Key Companies & Market Share Insights

The mesoporous silica market is highly competitive, with a broad array of manufacturers contributing to the overall market share. Leading firms are focusing on product development, strategic acquisitions, innovation, and regulatory approvals to strengthen their global presence.

Key Mesoporous Silica Companies:

• Merck KGaA
• American Elements
• nanoComposix, Inc.
• Taiyo Internationa
• Mitsubishi Chemical Corporation
• MKnano
• R. Grace & Co.
• AGC Chemicals Americas, Inc.
• Glantreo Ltd.
• ACS Material LLC

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The mesoporous silica market is poised for substantial growth over the forecast period, fueled by its diverse and expanding application base across pharmaceuticals, environmental treatment, and industrial synthesis. Although regulatory concerns and market consolidation may present challenges, ongoing R&D efforts and favorable trends in emerging economies—particularly in the Asia Pacific region—are expected to unlock significant opportunities for manufacturers and investors alike.

browse our blog: https://globalindustryherald.com